Mobile App

Google Play Apple Store
Independent Conference Coverage from the American College of Chest Physicians (CHEST) Annual Meeting 2023*
AMA/ANCC/ACPE Activity - Clinical Clips
Despite dramatic advances in the development of treatments for pulmonary arterial hypertension (PAH), it remains a chronic life-threatening illness for which there is no cure. Advances in knowledge within the field are eagerly anticipated.

These educational Clinical Clips will spotlight important research into the basic science, diagnosis, treatment, and medical management of patients with PAH based on data presented at the American College of Chest Physicians (CHEST) Annual Meeting in Honolulu, HI, October 8-11, 2023.
Review the activity and claim AMA, ANCC or ACPE credit/contact hour after completion of a brief pretest and posttest/evaluation.



Ronald Oudiz, MD, FACP, FACC, FCCP Ronald Oudiz, MD, FACP, FACC, FCCP
Professor of Medicine
The David Geffen School of Medicine at UCLA
Chief, Division of Cardiology
Director, Pulmonary Hypertension Clinic
Harbor-UCLA Medical Center

*This coverage is not sanctioned by the conference organizers and is not an official part of the conference proceedings of the American College of Chest Physicians (CHEST) Annual Meeting 2023.
20
Supported by independent educational grants from United Therapeutics, a public benefit company; Bayer U.S.; and Actelion Pharmaceuticals U.S., Inc., A Janssen Pharmaceutical Company of Johnson & Johnson

Launch Date: October 10, 2023
Release Date: October 9, 2023
Expiration Date: September 30, 2024

September 30, 2024
Mini Module
7621
ClinicalClips_PAH_1150x108.png
False
Pulmonology

CookieConsent

Change Settings